Document is current
Any future updates will be listed below
-
Authors
Paquette, Michel https://orcid.org/0000-0003-0468-4115
Phoenix, Serge
Lavallée, Éric
Rousseau, Jacques A.
Guérin, Brigitte
Turcotte, Éric E.
Lecomte, Roger
-
Funding
Funding for this research was provided by:
Canadian Breast Cancer Research Alliance
Natural Sciences and Engineering Research Council of Canada
- License Information
-
More Information
Article History
Received: 22 April 2020
Revised: 13 July 2020
Accepted: 15 July 2020
First Online: 22 July 2020
Compliance with Ethical Standards
:
: RL is a co-founder and chief scientific officer of IR&T Inc. who was involved in the development of the prototype ultra-high-resolution PET scanner LabPET II. The other authors have no conflict of interest to declare regarding this paper or the results therein.
: All animal procedures were approved by the Ethical Committee for Animal Care of the Université de Sherbrooke, in compliance with the policies and directives of the Canadian Council on Animal Care. Patients were retroactively analyzed from a previously reported phase II breast cancer clinical trial evaluating 4FMFES-PET, which was performed under the authority of Health Canada and approved by the Sherbrooke University Hospital Clinical Research Ethics Committee and Institutional Board.
